Rhu-pGSN for Acute Respiratory Distress Syndrome (ARDS)

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2024
BTI-203 is a randomized, double-blind, placebo-controlled, multicenter, Phase 2 proof-of-concept (POC) study to evaluate the efficacy and safety of rhu-pGSN plus standard of care (SOC) in subjects with moderate-to-severe ARDS (P/F ratio ≤150) due to pneumonia or other infections. Potential subjects hospitalized with pneumonia or other infections are to be screened within 24 hours of diagnosis of ARDS.
Epistemonikos ID: b525bb16be0928752871d87a0a9ec2d5821755bc
First added on: May 15, 2024